e, but are not limited to: risks associated with the
uncertainty of future financial results, our reliance on our sole supplier,
the limited diversification of our product offerings, additional financing
requirements, development of new products, government approval processes,
the impact of competitive products or pricing, technological changes, the
effect of economic conditions and other uncertainties detailed in the
Company's filings with the Securities and Exchange Commission. The Company
undertakes no obligation to update any forward-looking statements.
For More Information:
Corporate Information
Ph: (208) 288-5550
Toll Free: (800) 414-1901
Fax: (208) 288-1191
Investor Relations
Craig Bird, 215-885-4981
chbird@segue.biz
Segue Ventures LLC
'/>"/>SOURCE RxElite, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
RxElite Files Registration Statement with Securities and Exchange Commission2.
RxElite Announces 3rd Quarter Financials Conference Call3.
RxElite Registration Statement Declared Effective by Securities and Exchange Commission4.
RxElite Registration Statement Suspended5.
RxElite Announces Acquisition of Assets of FineTech Laboratories6.
RxElite Inc. Fourth Quarter and Year-End 2007 Earnings Release and Conference Call Notice7.
UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria8.
Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona9.
CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health10.
PartsSource Awarded US Patent for PartsFinder(TM) Application11.
Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance